Readers And Tweeters Dive Into Debate Over ‘Medicare For All’
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The independent source for health policy research, polling, and news.
5,381 - 5,400 of 15,451 Results
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Even in the event of an outbreak, employers have to follow certain rules in their efforts to protect employees from this virus.
Disease experts say a new coronavirus case in California underscores the need for more widespread community testing for the illness, as well as problems caused by the delays in getting functional coronavirus test kits to state and local public health agencies.
Official Washington is sitting up and taking notice of the threat from the novel coronavirus as Congress and the Trump administration prepare for a potential pandemic. Meanwhile, the Democratic candidates for president are still arguing about “Medicare for All.” Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Shefali Luthra of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews NPR’s Sydney Lupkin about the latest “Bill of the Month” installment.
In California’s rural Central Valley, low-income children have limited access to vision care. School districts are teaming up with nonprofits to fill the gaps.
Sarah and Andy fell in love while working to keep drug users from overdosing. But when his own addiction reemerged, Andy's fear of returning to prison kept him from the best treatment.
"CBS This Morning" looks at the latest "Bill of the Month" installment. A drug implant for children has a price tag of $37,300, while one used in adults with the same active ingredient goes for $4,400.
Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.
When patients need long-term treatment with intravenous antibiotics, hospitals usually let them manage their treatment at home — but not if they have a history of injection drug use. A Boston program wants to change that.
The stakes appeared higher in this debate as candidates focused on the upcoming South Carolina primary this weekend and Super Tuesday.
The research exaggerates potential savings, cherry-picks evidence and downplays some of the potential trade-offs.
It’s “déjà vu all over again.”
Because seniors are at higher risk of cognitive impairment, proponents say screening asymptomatic older adults is an important strategy to identify people who may be developing dementia and to improve their care. But the U.S. Preventive Services Task Force cited insufficient evidence the tests are helpful.
UnitedHealthcare is dropping hundreds of physicians from its New Jersey Medicaid network, separating patients from longtime doctors. Physicians charge the insurer is using its market power to shift business to practices it controls.
California has one of the lowest rates of new lung cancer cases in the country, attributed largely to its aggressive anti-tobacco policies. But gaps in the state’s health care system mean that people who are diagnosed with the disease, or at a high risk of getting it, often fall through the cracks.
The California Democratic members of Congress who flipped seven Republican seats two years ago made health care a major campaign issue, criticizing their opponents for voting to repeal the Affordable Care Act. As the Democrats defend their seats in this year’s elections, they are coming back to health care — but the issues are different.
A recent cardiac health dust-up between former New York City Mayor Mike Bloomberg and Sen. Bernie Sanders, both vying for the Democratic presidential nomination, focuses attention on this question.
Two drug implants are nearly identical. The one for children has a list price of $37,300. For adults, the list price is $4,400. One dad fought for his daughter to be able to use the cheaper drug.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
© 2026 KFF